97 related articles for article (PubMed ID: 30357843)
1. Tumor and endothelial cells collaborate via transcellular receptor complexes.
Sarabipour S; Mac Gabhann F
J Pathol; 2019 Feb; 247(2):155-157. PubMed ID: 30357843
[TBL] [Abstract][Full Text] [Related]
2. VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.
Morin E; Sjöberg E; Tjomsland V; Testini C; Lindskog C; Franklin O; Sund M; Öhlund D; Kiflemariam S; Sjöblom T; Claesson-Welsh L
J Pathol; 2018 Nov; 246(3):311-322. PubMed ID: 30027561
[TBL] [Abstract][Full Text] [Related]
3. Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.
Morin E; Lindskog C; Johansson M; Egevad L; Sandström P; Harmenberg U; Claesson-Welsh L; Sjöberg E
J Pathol; 2020 Apr; 250(4):387-396. PubMed ID: 31880322
[TBL] [Abstract][Full Text] [Related]
4. Use of NanoBiT and NanoBRET to monitor fluorescent VEGF-A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells.
Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
Br J Pharmacol; 2021 Jun; 178(12):2393-2411. PubMed ID: 33655497
[TBL] [Abstract][Full Text] [Related]
5. NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation.
Koch S; van Meeteren LA; Morin E; Testini C; Weström S; Björkelund H; Le Jan S; Adler J; Berger P; Claesson-Welsh L
Dev Cell; 2014 Mar; 28(6):633-46. PubMed ID: 24656741
[TBL] [Abstract][Full Text] [Related]
6. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI
Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992
[TBL] [Abstract][Full Text] [Related]
7. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
8. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
[TBL] [Abstract][Full Text] [Related]
10. Interactions between NRP1 and VEGFR2 molecules in the plasma membrane.
King C; Wirth D; Workman S; Hristova K
Biochim Biophys Acta Biomembr; 2018 Oct; 1860(10):2118-2125. PubMed ID: 29630862
[TBL] [Abstract][Full Text] [Related]
11. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
Quante M; Raskopf E; Stahl S; Vogt A; Sauerbruch T; Schmitz V
Oncol Rep; 2009 May; 21(5):1161-8. PubMed ID: 19360289
[TBL] [Abstract][Full Text] [Related]
12. VEGF-A121a binding to Neuropilins - A concept revisited.
Sarabipour S; Mac Gabhann F
Cell Adh Migr; 2018 May; 12(3):204-214. PubMed ID: 29095088
[TBL] [Abstract][Full Text] [Related]
13. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
14. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
[TBL] [Abstract][Full Text] [Related]
15. Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF-based binding assay.
Auriau J; Roujeau C; Belaid Choucair Z; Oishi A; Derviaux C; Roux T; Trinquet E; Hermine O; Jockers R; Dam J
Biochem Pharmacol; 2018 Dec; 158():45-59. PubMed ID: 30236477
[TBL] [Abstract][Full Text] [Related]
16. VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer.
Talagas M; Uguen A; Garlantezec R; Fournier G; Doucet L; Gobin E; Marcorelles P; Volant A; DE Braekeleer M
Anticancer Res; 2013 May; 33(5):2065-75. PubMed ID: 23645757
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
Becker PM; Waltenberger J; Yachechko R; Mirzapoiazova T; Sham JS; Lee CG; Elias JA; Verin AD
Circ Res; 2005 Jun; 96(12):1257-65. PubMed ID: 15920019
[TBL] [Abstract][Full Text] [Related]
18. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF.
Neufeld G; Kessler O; Herzog Y
Adv Exp Med Biol; 2002; 515():81-90. PubMed ID: 12613545
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.
Shintani Y; Takashima S; Asano Y; Kato H; Liao Y; Yamazaki S; Tsukamoto O; Seguchi O; Yamamoto H; Fukushima T; Sugahara K; Kitakaze M; Hori M
EMBO J; 2006 Jul; 25(13):3045-55. PubMed ID: 16763549
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 is a receptor for extracellular miRNA and AGO2/miRNA complexes and mediates the internalization of miRNAs that modulate cell function.
Prud'homme GJ; Glinka Y; Lichner Z; Yousef GM
Oncotarget; 2016 Oct; 7(42):68057-68071. PubMed ID: 27486976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
